Amy Goodman, CBSA’s Vice President & Counsel for Policy + Advocacy, attended the 2023 Annual Council of State Bioscience Associations (CSBA) Summit in New Orleans this past week and discussed Colorado’s experience in a panel on Prescription Drug Affordability Boards (PDABs). Amy was joined by CBSA Board Chair Kathleen (Kiki) Traylor, MD, Director of State Government Affairs for Amgen, along with Kelly Schulz, CEO of Maryland Tech Council, and Stephen Rapundalo, PhD, President and CEO of MichBio.
The panel, moderated by Brian Warren, Senior Director of State Government Relations for BIO, provided attendees with an understanding of what PDABs are, discussed the potential negative consequences for biotech innovation and patient access, described the experience of states that have implemented or attempted to pass PDABs, and provided insights and resources for CSBA affiliates facing potential PDAB legislation in their…
Click here to view original post
